Glaucoma surgery during the first year of the COVID-19 pandemic

Rosa Longo; Elia Franzolin; Emilio Pedrotti; Adriano Fasolo; Erika Bonacci; Giorgio Marchini

doi:10.1007/s10792-022-02278-6

Glaucoma surgery during the first year of the COVID-19 pandemic

Int Ophthalmol. 2022 Sep;42(9):2881-2887. doi: 10.1007/s10792-022-02278-6. Epub 2022 Apr 16.

Authors

Rosa Longo¹, Elia Franzolin², Emilio Pedrotti², Adriano Fasolo², Erika Bonacci², Giorgio Marchini²

Affiliations

¹ Department of Neurosciences, Biomedicine and Movement Sciences, Ophthalmic Unit, University of Verona, P.le L. A. Scuro 10, 37134, Verona, Italy. rosa.longo@univr.it.
² Department of Neurosciences, Biomedicine and Movement Sciences, Ophthalmic Unit, University of Verona, P.le L. A. Scuro 10, 37134, Verona, Italy.

Abstract

Purpose: To summarize the actions taken to give continuity to the surgical treatment of glaucoma patients and to present the volume and characteristics of glaucoma surgery in the first year of pandemic at the Tertiary Glaucoma Center of the University Hospital of Verona (Veneto, Italy).

Methods: Demographical and surgical features of patients who underwent glaucoma surgery from March 9th, 2020 to March 8th, 2021 have been collected and compared to the same date range of the previous year. The analyzed data included age, gender, region of origin, glaucoma staging, type of anesthesia and surgical procedure.

Results: The surgical volume of glaucoma has dropped by 30.1%. In comparison with the previous year, we found a significant variation in the overall distribution of the performed surgical procedures (p < 0.001). There was a decline in Baerveldt tube implants (- 4.9%), and an increase of non-penetrating surgery (+ 2.6%), cyclo-photo ablative procedures (+ 4.2%) and MIGS (+ 5.7%). Only 24.3% of the procedures were performed under general anesthesia compared to 41.5% in the pre-pandemic period (p < 0.001). The number of procedures performed on eyes affected by advanced or end-stage glaucoma is doubled (p < 0.001).

Conclusions: To give continuity to glaucoma surgery, we prioritized interventions on patients with poorer visual fields, rapidly progressing visual field deficit and elevated IOP uncontrolled by maximal medical therapy. Secondly, we have rescheduled the other interventions following the same priority criteria. Finally, we managed some lower priority cases with MIGS, minimizing the need for close post-intervention follow-up. Considering the negative consequences that a delay in the management of glaucoma can have in terms of visual loss, the closure of the operating rooms in the first quarter of the pandemic was detrimental. It appears that glaucoma surgery deserves urgencies that cannot be overshadowed and the greatest effort must be to give continuity to this type of eye surgery.

Keywords: COVID-19 pandemic; Eye; Glaucoma; Surgery.

MeSH terms

COVID-19*
Follow-Up Studies
Glaucoma Drainage Implants*
Glaucoma*
Humans
Intraocular Pressure
Pandemics
Retrospective Studies
Treatment Outcome